story of the week
SGLT2 Inhibitors and Diabetic Ketoacidosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SGLT2 Inhibitors and Diabetic Ketoacidosis: Data From the FDA Adverse Event Reporting System
Diabetologia 2017 May 12;[EPub Ahead of Print], GP Fadini, BM Bonora, A AvogaroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.